Stage FocusSeed, Series A, Series B+
GeographyUK, Europe
TypeUniversity VC
Last Activity2025
Industry Focus
Industries
BiotechMedtechQuantumFusionAIAgritechEnergy Tech
Technical BenchStrong
Investor TypeUniversity Fund
ExposureMostly DeepTech Investments
Bio
Oxford Science Enterprises was founded in 2015 as an independent investment company with a unique partnership with the University of Oxford. The firm manages £1.1B and secured a £175M NAV financing facility from Deutsche Bank and Goldman Sachs in March 2025 to support further growth.
The core portfolio consists of roughly 40 companies across life sciences, health tech, and deep tech. The headline...
Notable Investments
V
VaccitechF
First Light FusionO
ORCA ComputingB
Base GenomicsO
OMass TherapeuticsSimilar Funds
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantumSemiconductorsSeedSeries A
NV
Navigare Ventures
Stockholm, Sweden
Pure DeepTechBiotechSemiconductorsAdvanced MaterialsSeedSeries A
NS
Neva SGR
Turin, Italy
Industrial / CVCBiotechSpaceFusionSeedSeries A
Parkwalk Advisors
London, United Kingdom
DeepTech NativeBiotechAIQuantumSeedSeries A
Ahren Innovation Capital
London, United Kingdom
DeepTech NativeBiotechRoboticsClimate TechSeedSeries A
HV
Hummingbird VC
London, United Kingdom
GeneralistBiotechAIBlockchainPre-SeedSeed